Natwarlal V Ramani Md - Medicare Primary Care in Dover, DE

Natwarlal V Ramani Md is a medicare enrolled primary clinic (Internal Medicine) in Dover, Delaware. The current practice location for Natwarlal V Ramani Md is 742 S Governors Ave, Suite 3, Dover, Delaware. For appointments, you can reach them via phone at (302) 678-5008. The mailing address for Natwarlal V Ramani Md is 742 S Governors Ave, Suite 3, Dover, Delaware and phone number is (302) 678-5008.

Natwarlal V Ramani Md is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1033142815. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (302) 678-5008.

Contact Information

Natwarlal V Ramani Md
742 S Governors Ave
Suite 3
Dover
DE 19904-4111
(302) 678-5008
(302) 678-5505

Primary Care Clinic Profile

Full NameNatwarlal V Ramani Md
SpecialityInternal Medicine
Location742 S Governors Ave, Dover, Delaware
Authorized Official Name and PositionNatwarlal V Ramani (OWNER PRESIDENT)
Authorized Official Contact3026785008
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Natwarlal V Ramani Md
742 S Governors Ave
Suite 3
Dover
DE 19904-4111

Ph: (302) 678-5008
Natwarlal V Ramani Md
742 S Governors Ave
Suite 3
Dover
DE 19904-4111

Ph: (302) 678-5008

NPI Details:

NPI Number1033142815
Provider Enumeration Date07/08/2006
Last Update Date08/22/2020

Medicare PECOS Information:

Medicare PECOS PAC ID9234279258
Medicare Enrollment IDO20091222000475

News Archive

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Experimental cancer drug shows promise against incurable paediatric brain cancer

US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).

Study calls for effective strategies to contain potential HDV epidemic in high-risk populations

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country.

More exercise equals lower risk of ischemic stroke

Even in an Asian nation where people generally have higher levels of physical activity on the job than is typical in North America or Europe, those who walk more or engage in regular sports activity tend to have lower levels of ischemic stroke and coronary heart disease

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

Read more Medical News

› Verified 1 days ago

Medical Identifiers

Medical identifiers for Natwarlal V Ramani Md such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033142815NPI-NPPES
0000845502MedicaidDE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Natwarlal V Ramani Md acts as a billing entity for following providers:
Provider NameBetty J Holmes
Provider TypePractitioner - Certified Registered Nurse Anesthetist (crna)
Provider IdentifiersNPI Number: 1528034097
PECOS PAC ID: 7416855788
Enrollment ID: I20031223000464

News Archive

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Experimental cancer drug shows promise against incurable paediatric brain cancer

US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).

Study calls for effective strategies to contain potential HDV epidemic in high-risk populations

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country.

More exercise equals lower risk of ischemic stroke

Even in an Asian nation where people generally have higher levels of physical activity on the job than is typical in North America or Europe, those who walk more or engage in regular sports activity tend to have lower levels of ischemic stroke and coronary heart disease

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

Read more Medical News

› Verified 1 days ago

Provider NameNatwarlal V Ramani
Provider TypePractitioner - Gastroenterology
Provider IdentifiersNPI Number: 1285681098
PECOS PAC ID: 0840330866
Enrollment ID: I20101020001274

News Archive

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Experimental cancer drug shows promise against incurable paediatric brain cancer

US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).

Study calls for effective strategies to contain potential HDV epidemic in high-risk populations

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country.

More exercise equals lower risk of ischemic stroke

Even in an Asian nation where people generally have higher levels of physical activity on the job than is typical in North America or Europe, those who walk more or engage in regular sports activity tend to have lower levels of ischemic stroke and coronary heart disease

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

Read more Medical News

› Verified 1 days ago

Provider NameBrian J Plasil
Provider TypePractitioner - Pathology
Provider IdentifiersNPI Number: 1164638151
PECOS PAC ID: 7113056078
Enrollment ID: I20120127000852

News Archive

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Experimental cancer drug shows promise against incurable paediatric brain cancer

US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).

Study calls for effective strategies to contain potential HDV epidemic in high-risk populations

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country.

More exercise equals lower risk of ischemic stroke

Even in an Asian nation where people generally have higher levels of physical activity on the job than is typical in North America or Europe, those who walk more or engage in regular sports activity tend to have lower levels of ischemic stroke and coronary heart disease

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

Read more Medical News

› Verified 1 days ago

Provider NameCarl C Gable
Provider TypePractitioner - Pathology
Provider IdentifiersNPI Number: 1942416011
PECOS PAC ID: 3779657556
Enrollment ID: I20190718001084

News Archive

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Experimental cancer drug shows promise against incurable paediatric brain cancer

US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).

Study calls for effective strategies to contain potential HDV epidemic in high-risk populations

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country.

More exercise equals lower risk of ischemic stroke

Even in an Asian nation where people generally have higher levels of physical activity on the job than is typical in North America or Europe, those who walk more or engage in regular sports activity tend to have lower levels of ischemic stroke and coronary heart disease

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

Read more Medical News

› Verified 1 days ago

Provider NameSahil Rajesh Patel
Provider TypePractitioner - Gastroenterology
Provider IdentifiersNPI Number: 1336403591
PECOS PAC ID: 8224343389
Enrollment ID: I20200602000008

News Archive

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Experimental cancer drug shows promise against incurable paediatric brain cancer

US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).

Study calls for effective strategies to contain potential HDV epidemic in high-risk populations

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country.

More exercise equals lower risk of ischemic stroke

Even in an Asian nation where people generally have higher levels of physical activity on the job than is typical in North America or Europe, those who walk more or engage in regular sports activity tend to have lower levels of ischemic stroke and coronary heart disease

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

Read more Medical News

› Verified 1 days ago

Provider NameKenneth Apollo Musana
Provider TypePractitioner - Gastroenterology
Provider IdentifiersNPI Number: 1952401697
PECOS PAC ID: 0042272270
Enrollment ID: I20220726002825

News Archive

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Experimental cancer drug shows promise against incurable paediatric brain cancer

US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).

Study calls for effective strategies to contain potential HDV epidemic in high-risk populations

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country.

More exercise equals lower risk of ischemic stroke

Even in an Asian nation where people generally have higher levels of physical activity on the job than is typical in North America or Europe, those who walk more or engage in regular sports activity tend to have lower levels of ischemic stroke and coronary heart disease

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

Read more Medical News

› Verified 1 days ago

News Archive

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

Experimental cancer drug shows promise against incurable paediatric brain cancer

US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).

Study calls for effective strategies to contain potential HDV epidemic in high-risk populations

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country.

More exercise equals lower risk of ischemic stroke

Even in an Asian nation where people generally have higher levels of physical activity on the job than is typical in North America or Europe, those who walk more or engage in regular sports activity tend to have lower levels of ischemic stroke and coronary heart disease

Too much transparency in clinical trials data may inhibit drug development, says researchers

New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development might be problematic, according to Timo Minssen, researcher at the University of Copenhagen.

Read more News

› Verified 1 days ago


Internal Medicine in Dover, DE

Middletown Wellness Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 417 Federal St, Dover, DE 19901
Phone: 302-744-4849    Fax: 302-739-6627
Northeast Family Planning
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 417 Federal St, Dover, DE 19901
Phone: 302-744-4548    Fax: 302-739-1613
Kent Epsdt
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 417 Federal St, Dover, DE 19901
Phone: 302-744-4548    Fax: 302-739-1613
Lee Dennis, M.d.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 960 Forest St, Dover, DE 19904
Phone: 302-735-1888    
Dph Seaford Family Planning
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 417 Federal St, Dover, DE 19901
Phone: 302-744-4548    Fax: 302-739-1613
Cdw South
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 417 Federal St, Dover, DE 19901
Phone: 302-744-4548    Fax: 302-739-1613

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.